Tamar Safra
- Oncology top 0.5%
- Reproductive Medicine top 0.1%
- Molecular Biology top 5%
- Genetics top 1%
- Biomaterials top 1%
- Co-authors
- Michael FriedländerIgnace VergoteCharlie GourleyUrsula A. MatulonisAlberto GabizónRonnie Shapira‐FrommerJonathan A. LedermannPhilipp Harter
- Topics
- Ovarian cancer diagnosis and treatment (52 papers)BRCA gene mutations in cancer (31 papers)PARP inhibition in cancer therapy (26 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Tamar Safra
92 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 4.0k
- Reproductive Medicine 2.5k
- Molecular Biology 2.5k
- Genetics 1.2k
- Biomaterials 960
Countries citing papers authored by Tamar Safra
This map shows the geographic impact of Tamar Safra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Safra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Safra more than expected).
Fields of papers citing papers by Tamar Safra
This network shows the impact of papers produced by Tamar Safra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Safra. The network helps show where Tamar Safra may publish in the future.
Co-authorship network of co-authors of Tamar Safra
This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Safra. A scholar is included among the top collaborators of Tamar Safra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Safra. Tamar Safra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 6 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 10 | |
| 9 | 5 | |
| 10 | 13 | |
| 11 | 186 | |
| 12 | Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer | 1 |
| 13 | 14 | |
| 14 | 22 | |
| 15 | 27 | |
| 16 | 378 | |
| 17 | Fulvestrant in heavily pretreated metastatic breast cancer: is it still effective as a very advanced line of treatment? | 3 |
| 18 | Herceptin (trastuzumab): adjuvant and neoadjuvant trials. | 7 |
| 19 | 19 | |
| 20 | 35 |
About Tamar Safra
Tamar Safra is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 102 papers that have together received 6.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (52 papers), BRCA gene mutations in cancer (31 papers) and PARP inhibition in cancer therapy (26 papers). The work is most often cited by research in Reproductive Medicine (2.5k citations), Oncology (4.0k citations) and Biomaterials (960 citations). Tamar Safra has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Michael Friedländer, Ignace Vergote, Charlie Gourley, Ursula A. Matulonis, Alberto Gabizón, Ronnie Shapira‐Frommer, Jonathan A. Ledermann, Philipp Harter, Daniela Matei and Werner Meier. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.